Value Analysis of Biopharmaceutical Industry Investment

Based on China’s A-share Market

DOI

10.2991/aebmr.k.220603.062How to use a DOI?

Keywords

biopharmaceuticals; value investing; financial indicators; correlation analysis

Abstract

In order to deeply understand the long-term value investment of the biomedical sector, this paper analyzes the fundamentals by using financial indicators. From the economic perspective, the financial data of biomedicine in a-share market in recent ten years are used to analyze the market performance, profitability, debt-paying ability, growth and valuation level. Finally, the correlation analysis discusses selected indicators and investigates the relationship between the biomedicine market and the A-share market. Through statistical analysis and correlation analysis, it is found that China’s biomedical sector is superior to the A-share (non-financial) sector in terms of solvency, profitability and growth, with a growing trend. In terms of valuation, the overall performance of the biomedical industry is better than that of A-shares (non-financial), and there is A strong positive correlation between the profitability and growth of the sector and the market performance of the sector.

Copyright

© 2022 The Authors. Published by Atlantis Press International B.V.

Open Access

This is an open access article distributed under the CC BY-NC 4.0 license.

Download article (PDF)

TY  - CONF
AU  - Xinyi Rao
PY  - 2022
DA  - 2022/07/01
TI  - Value Analysis of Biopharmaceutical Industry Investment
BT  - Proceedings of the 2022 2nd International Conference on Enterprise Management and Economic Development (ICEMED 2022)
PB  - Atlantis Press
SP  - 375
EP  - 383
SN  - 2352-5428
UR  - https://doi.org/10.2991/aebmr.k.220603.062
DO  - 10.2991/aebmr.k.220603.062
ID  - Rao2022
ER  -